Jacobs Engineering Group has secured a deal to build a facility for pharmaceutical company Pfizer to manufacture gene therapy products.
Jacobs said Thursday it will also design and qualify the multiproduct factory to be constructed at the drugmaker’s Sanford, North Carolina, production site.
“Working on this project, we envision a day in the future when these potentially transformative gene therapies become available to treat medical conditions to help people enjoy healthier lives,” said Ken Gilmartin, senior vice president and general manager of Jacobs’ life sciences, consumer goods and manufacturing business.
The company will also provide expediting and commissioning services to the construction project.
Gene therapy is an emerging medical research area that looks to discover specialized treatments intended to address medical diseases caused by genetic mutation.